FRONTIER IP GROUP PLC

Board/Management Information • Sep 26, 2018

National Storage Mechanism | Additional information

You don't have Javascript enabled. For full functionality this page requires javascript to be enabled.

RNS Number : 0695C

Frontier IP Group plc

26 September 2018

26 September 2018

Frontier IP Group plc

("Frontier IP" or the "Group")

Director Declaration

Frontier IP, which specialises in commercialising university intellectual property, makes the following updated disclosures in respect of Neil Crabb, CEO of Frontier IP, pursuant to Schedule 2(g) of the AIM Rules for Companies:

a)            Mr Crabb was appointed as a director of B1 Medical Limited on 14 July 2006 and was a director when the company entered into compulsory liquidation on 1 November 2012. B1 Medical Limited was dissolved on 5 February 2013.

b)            Mr Crabb was appointed as a director of Intelligent Flow Solutions Limited on 27 March 2012 and was a director when the company entered into compulsory liquidation on 26 October 2016.

There are no further disclosures required pursuant to Schedule 2(g).

Enquiries:

Frontier IP Group plc	T: 0131 240 1251
Neil Crabb, Chief Executive
Andrew Johnson, Communications & Investor Relations	M: 07464 546 025
www.frontierip.co.uk
Cenkos Securities plc (Nominated Adviser and Joint Broker)	T: 0131 220 6939
Neil McDonald / Beth McKiernan
Peterhouse Corporate Finance Limited (Joint Broker)	T: 020 7469 0935
Lucy Williams
Kreab (Financial PR)	T: 0207 074 1800
Robert Speed / Matthew Jervois

Notes to Editors:

Frontier IP unites science and commerce by identifying strong intellectual property and accelerating its development through a range of commercialisation services.

The Group looks to build and grow a portfolio of equity stakes and licence income by taking an active involvement in spin-out companies, including support for fund raising and collaboration with relevant industry partners at an early stage of development.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

END

RDNMMGZLVVGGRZM